• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    GlaxoSmithKline plc (GSK)

    -NYSE
    47.20 Up 0.18(0.38%) Mar 30, 4:02PM EDT
    |Pre-Market : 46.34 Down 0.86 (1.82%) 7:47AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:47.02
    Open:46.98
    Bid:46.24 x 700
    Ask:46.27 x 1100
    1y Target Est:46.36
    Beta:0.96
    Next Earnings Date:N/A
    Day's Range:46.92 - 47.24
    52wk Range:41.25 - 56.48
    Volume:2,417,787
    Avg Vol (3m):3,799,670
    Market Cap:113.54B
    P/E (ttm):28.03
    EPS (ttm):1.68
    Div & Yield:2.78 (6.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GSKUp 0.38%113.54B
    MRKUp 1.02%165.58B
    NVSUp 0.91%243.00B
    PFEUp 1.36%214.51B

    Key Statistics

    Forward P/E (1 yr):17.29
    P/S (ttm):3.33
    Ex-Dividend Date:18-Feb-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback